Guardian Capital Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.59M | Hold |
1,786,414
| – | – | 0.45% | 65 |
|
|
2024
Q2 | $5M | Hold |
1,786,414
| – | – | 0.53% | 61 |
|
|
2024
Q1 | $7M | Hold |
1,786,414
| – | – | 0.75% | 47 |
|
|
2023
Q4 | $10.7M | Hold |
1,786,414
| – | – | 1.11% | 29 |
|
|
2023
Q3 | $7.84M | Hold |
1,786,414
| – | – | 0.88% | 38 |
|
|
2023
Q2 | $13.5M | Hold |
1,786,414
| – | – | 1.53% | 18 |
|
|
2023
Q1 | $13M | Hold |
1,786,414
| – | – | 1.5% | 20 |
|
|
2022
Q4 | $18.2M | Sell |
1,786,414
-1,950,000
| -52% | -$19.9M | 2.07% | 11 |
|
|
2022
Q3 | $40.1M | Sell |
3,736,414
-100,000
| -3% | -$1.07M | 5.01% | 3 |
|
|
2022
Q2 | $44.4M | Hold |
3,836,414
| – | – | 5.09% | 3 |
|
|
2022
Q1 | $34.6M | Hold |
3,836,414
| – | – | 3.37% | 5 |
|
|
2021
Q4 | $45.3M | Hold |
3,836,414
| – | – | 4.36% | 3 |
|
|
2021
Q3 | $76.8M | Sell |
3,836,414
-139,580
| -4% | -$2.79M | 7.97% | 1 |
|
|
2021
Q2 | $81.4M | Buy |
+3,975,994
| New | +$81.4M | 8.35% | 1 |
|